IL-6 Blocker Stops RA Joint Damage - MedPage Today

MedPage Today

IL-6 Blocker Stops RA Joint Damage MedPage Today Treatment of rheumatoid arthritis with an anti-interleukin (IL)-6 receptor antibody significantly slows the progression of joint damage even in patients who continue to have active disease, a post-hoc analysis revealed. After a year of treatment, ...

The Road to Remission in RA, a Clinical Context Report - MedPage Today

The Road to Remission in RA, a Clinical Context Report MedPage Today For instance, seropositive rheumatoid arthritis, lupus, Sjogren's, anything that has an antibody associated with it. Might they be somebody who fits in the spondyloarthropathy bucket? Will they have psoriatic arthritis, ankylosing spondylitis, ... and more »

Priority Health: RA treatment - Bay News 9

Bay News 9

Priority Health: RA treatment Bay News 9 By Dr. Randy Shuck, Medical reporter A new report released recently shows that there are several treatment available to treat rheumatoid arthritis (RA). I thought it would be a good idea to review RA and list some of the treatments available, ...

Cimzia (certolizumab pegol) shows positive top-line phase 3 results in axial ... - PharmaLive.com (press release)

Cimzia (certolizumab pegol) shows positive top-line phase 3 results in axial ... PharmaLive.com (press release) In the US, Cimzia® is approved for the treatment of adults with moderately to severely active rheumatoid arthritis. In the US, Cimzia® is also approved for reducing the signs and symptoms of Crohn's disease and maintaining clinical response in adult ... and more »